Why Stoke Therapeutics’ Dravet syndrome drug is worth watching
Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial for its experimental drug for Dravet syndrome.
Related Articles
How pediatricians use AI tools to speed diagnosis, help kids
AMA member and pediatrician Colleen Kraft, MD, encourages physicians to put test out whether the tech is the right fit for their practice.
YouTube singer arrested in Iran after performing an online concert while not wearing a hijab
Iranian authorities have arrested a female singer who performed a virtual concert on YouTube, a lawyer said.
From the UFOs community on Reddit: Eastport, Maine
Explore this post and more from the UFOs community
Dr. David Lubarsky to leave UC Davis Health
UC Davis Health CEO Dr. David Lubarsky on Feb. 17 will join Westchester County Health Care Corporation in Valhalla, New York.
5 Yoga Poses You Can Do Right Now To Strengthen Your Core
The gluteal muscles, diaphragm, hip flexors, hip adductor muscles and pelvic floor also comprise your core. These large muscle groups help control the movements you…
FCC throws open 6 GHz band to unlicensed low-power gizmos
Good news for techies pushing ‘education, healthcare, and entertainment’ gadgets in the US
Patients Couldn’t Pay Their Utility Bills. One Hospital Turned to Solar Power for Help. – KFF Health News
Doctors in Boston got tired of writing letters to utility companies asking for assistance for their medically vulnerable patients who need power and heat to…
Study shows US obesity rates falling for first time in more than a decade | Fox News Video
Fox News senior medical analyst Dr. Marc Siegel provides insight into whether weight loss drugs are playing a role in lowering obesity rate on ‘Fox…
Malaria cases in India drop by 93%, deaths fall by 68%: WHO report
India has significantly reduced malaria cases and deaths. India’s efforts, including community health initiatives and protective measures, have led to a 69% drop in cases…
New study reveals how stray dogs in Chernobyl managed to survive 40 years of radiation through genetic adaptations
Decades after the Chernobyl disaster, stray dogs have surprisingly adapted to the high radiation levels. A recent groundbreaking study shows these dogs, now